The image shows computationally derived structure of a cancer causing protein bound to DNA, the genetic material it controls

New Welsh company to target some common Welsh cancers

 A new Welsh start-up company is to develop a novel cancer therapy, targeting a rare bone cancer and other cancers, more common in Wales, such as lung, colorectal, breast and prostate cancers.

It looks like you’re visiting from outside the UK, would you like to be redirected to the international page?